Key result
Electrical cardioversion and cavutilide show comparable efficacy for restoring sinus rhythm in persistent AF.
Why the study?
To analyze modern approaches to the use of electrical and pharmacological cardioversion in patients with persistent atrial fibrillation.
What are the comparative efficacy and safety profiles of electrical versus pharmacological cardioversion in patients with persistent atrial fibrillation?
What are the comparative efficacy and safety profiles of electrical versus pharmacological cardioversion in patients with persistent atrial fibrillation?
The choice between electrical and pharmacological cardioversion for restoring sinus rhythm in persistent atrial fibrillation should be individualized based on patient characteristics and specific procedural risks.
May inform individualized cardioversion selection in persistent AF; leaves open prospective safety and outcome trials.
The objective was to analyze modern approaches to the use of electrical and pharmacological cardioversion in patients with persistent atrial fibrillation (AF). Materials and methods. A non-systematic literature review was conducted. Russian publications were searched in the eLibrary database, and international publications were sourced from PubMed and Google Scholar. Results. Cardioversion in patients with persistent AF employs either electrical cardioversion (ECV) or pharmacological cardioversion with cavutilide. ECV demonstrates high efficacy and a low rate of adverse events. However, its effectiveness depends on patients’ constitutional characteristics. Additionally, ECV requires total intravenous anesthesia, which may lead to sedation-related adverse events. Pharmacological cardioversion with cavutilide shows comparable efficacy to ECV. Studies indicate a favorable safety profile for cavutilide; however, due to the risk of proarrhythmic events, strict adherence to administration protocols and extended post-procedural monitoring in intensive care unit are obligatory. Conclusion . The choice of the optimal method for restoring sinus rhythm in patients with persistent AF should be individualized.
No takes yet. Share an insight, caveat, or question.
Kalmanson et al. (2025) conducted a review in Persistent and long-standing persistent atrial fibrillation. Electrical cardioversion and pharmacological cardioversion (cavutilide) was evaluated. Electrical cardioversion and pharmacological cardioversion with cavutilide show comparable efficacy for restoring sinus rhythm in patients with persistent atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: